CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Somatropin (rDNA origin)

Last Updated: June 12, 2009
Result type: Reports
Project Number: S0167
Product Line: Common Drug Review

Generic Name: Somatropin (rDNA origin)

Brand Name: Omnitrope

Manufacturer: Sandoz Canada Inc.

Indications: Growth hormone deficiency in children and adults

Submission Type: New

Project Status: Complete

Advice Issued: December 16, 2009